Novo Nordisk

NovoCare Patient Assistance Program

Free Novo Nordisk diabetes meds for income-qualified patients. ≤400% FPL for most products; ≤200% FPL for Ozempic (uninsured).

Doctor signature neededUninsured only

What you need to enroll

Your doctor needs to sign part of the application

This program requires a prescriber signature. The easiest path: download the application, bring it to your next appointment, and have the office fax it in for you.

Your copay

Free

Eligible patients pay $0. See the eligibility checklist below to confirm you qualify.

Download form for your doctor

Covered medications

Ozempic (semaglutide injection) — uninsured patients only † 0.25/0.5 mg pen·1 mg pen·2 mg pen
Xultophy 100/3.6 (insulin degludec + liraglutide) 5 pens x 3 mL/pen
Fiasp (insulin aspart) 10 mL vial·FlexTouch (5 pens × 3 mL)·PenFill (5 × 3 mL)
Novolin (human insulin) R 10 mL vial·N 10 mL vial·70/30 10 mL vial
NovoLog (insulin aspart) 10 mL vial·FlexPen (5 pens × 3 mL)·PenFill cartridge (5 × 3 mL)
NovoLog Mix 70/30 10 mL vial·FlexPen (5 pens × 3 mL)
Tresiba (insulin degludec) U-100 10 mL vial·U-100 FlexTouch (5 pens × 3 mL)·U-200 FlexTouch (3 pens × 3 mL)
NovoPen Echo (device)
NovoFine 32G needles (100/box) — only for FlexPen / FlexTouch / Xultophy users

Am I eligible?

Need a prescription?: Yes — written by a licensed prescriber for the medications below.
Insurance required?: Uninsured patients only — not for anyone with insurance.
State restrictions?: Available nationwide.
Income limits?: Yes — household income limits apply. Verify with the program.

Who qualifies

US resident
Household income ≤ 400% FPL (≤200% FPL for Ozempic uninsured)
Uninsured OR Medicare Part D (excluding Ozempic 2026 onward)
Not enrolled in Medicaid, LIS/Extra Help, or VA Benefits
Has a Novo Nordisk Rx and an HCP signature on the application

Accepted

US resident, age 18+
Household income at or below 400% FPL (≤200% FPL for Ozempic uninsured)
Uninsured, or Medicare Part D (Medicare Part D NOT eligible for Ozempic as of 2026)
Has a current Novo Nordisk Rx

Not accepted

Commercial insurance with adequate Novo Nordisk drug coverage
Households above the applicable FPL limit
Enrolled in or eligible for Medicaid, Medicare LIS / Extra Help, or VA Benefits
Medicare Part D beneficiaries seeking Ozempic (2026 exclusion)
Wegovy, Rybelsus, and Victoza (not on the 2026 PAP product list)
Non–Novo Nordisk medications

How to apply

Visit diabetespap.novocare.com and submit the patient portion online
Provide your healthcare provider's email — they'll receive a secure link to complete their portion
If prompted, upload supporting docs: Proof of Income, Medicaid LIS Denial, Government ID
If approved, Neovance Specialty Pharmacy (1-800-488-5908) will call to schedule home delivery
Program contact: 1-866-310-7549

Using it at the pharmacy

This is patient assistance — Novo Nordisk's Neovance Specialty Pharmacy (1-800-488-5908) ships the medication directly to the patient's home. No pharmacy handoff once approved.

Terms & limits

Fills per year: 4 fills per year, per covered drug
Renewal: Renew every year

Download form for your doctor

Income tiers by product/insurance: (1) Most Novo Nordisk products: ≤400% FPL. (2) Ozempic UNINSURED: ≤200% FPL only. (3) Ozempic Medicare Part D: NOT ELIGIBLE — Medicare patients should use the Medicare Prescription Payment Plan (MPPP) instead. (4) Medicare patients on Novo Nordisk INSULINS: ≤400% FPL, but if income is below 150% FPL you must provide proof of denial for Part D Extra Help. Uninsured patients in states with high FPL thresholds must provide proof of Medicaid denial before enrollment. Wegovy, Rybelsus, and Victoza are NOT covered by the PAP. Levemir was discontinued by Novo Nordisk in the US on Dec 31, 2024 and is no longer in the PAP. Document ID NNIPAP_11_01012026.

Be first when we launch — we'll save these matches and remind you to renew.

Join the waitlist

Download form for your doctor